ライフサイエンスコーパス: kansasii

1 as Mycobacterium ulcerans and Mycobacterium kansasii.

2 aded forms of Mycobacterium gordonae from M. kansasii.

3 of differing virulence and by Mycobacterium kansasii.

4 was greater than smooth "M. canettii" and M. kansasii.

5 nd 83, 95, 59, and 98%, respectively, for M. kansasii.

6 from three of the patients again revealed M. kansasii.

7 M. avium, 3 M. intracellulare complex, 3 M. kansasii, 4 M. gordonae, and 5 M. chelonae group (all we

8 .35 degrees C (63.27 to 65.42 degrees C); M. kansasii, 59.20 degrees C (58.07 to 60.33 degrees C); M.

9 evel, with the exception of one strain of M. kansasii (accurately identified but with a low spectral

10 pecies I is the predominant subspecies of M. kansasii among clinical isolates in the United States, a

11 Mycobacterium kansasii, an unusual pathogen in the pre-AIDS era, is in

12 One patient's culture contained both M. kansasii and M. avium, but none of the initial or follow

13 M. kansasii and M. smegmatis also grew very poorly in acidi

14 rarely occur, are genetically related to M. kansasii and morphologically difficult to distinguish.

15 All five isolates of M. kansasii and three of three isolates of M. simiae yielde

16 owing mycobacteria, 100% of patients with M. kansasii, and 0% of patients with M. gordonae.

17 Fourteen patients were treated for M kansasii, and 10 (71%) showed clinical and radiographic

18 acterium avium complex, 4 grew Mycobacterium kansasii, and 2 grew Mycobacterium tuberculosis); 42 iso

19 8% were M. abscessus), 78% (29 of 37) for M. kansasii, and 26% (9 of 35) for M. gordonae.

20 rowing NTM, including 7/7 M. marinum, 7/7 M. kansasii, and 7/11 of other less commonly isolated speci

21 ycobacterial species, M. scrofulaceum and M. kansasii, and eight of the environmental mycobacterial i

22 with little to no seroreactivity against M. kansasii- and M. avium subsp. paratuberculosis-infected

23 gainst Mycobacterium avium and Mycobacterium kansasii as well as Mycobacterium tuberculosis.

24 ing three of these patients' isolates and M. kansasii ATCC 12478), and cultures of several other spec

25 rown in liquid medium, whereas Mycobacterium kansasii can be larger and cross-barred.

26 An M. kansasii, DeltaMKAN27435 partially lipooligosaccharide-d

27 ycobacterium tuberculosis, and Mycobacterium kansasii enter macrophages, using the complement recepto

28 Patients with AIDS and pulmonary M kansasii frequently demonstrate focal alveolar opacities

29 y also distinguished the ESAT-6-secreting M. kansasii from the non-ESAT-6-secreting M. simiae.

30 of 76 (83%) of the specimens positive for M. kansasii, giving sensitivities specificities, positive p

31 Mycobacterium avium complex or Mycobacterium kansasii, half of which were detected by Direct LPA.

32 Persons infected with HIV and M. kansasii have a higher rate of hospitalization and a gre

33 s, Histoplasma capsulatum, and Mycobacterium kansasii impairs the constitutive production of IL-12 fr

34 Five cultures of M. kansasii (including three of these patients' isolates an

35 erium bovis bacillus Calmette-Guerin, and M. kansasii) induced significantly more AMphi apoptosis tha

36 -positive persons, but most patients with M. kansasii infection have clinical and radiologic evidence

37 epidemiology and clinical implications of M. kansasii infection in the AIDS era.

38 Mycobacterium avium complex or Mycobacterium kansasii infection.

39 The fact that a single clone of M. kansasii is responsible for most cases of human disease

40 ied the population genetics of Mycobacterium kansasii isolates from the United States by PCR restrict

41 resistant M. tuberculosis and Mycobacterium kansasii isolates mapped to hadC.

42 One M. fortuitum isolate and one of five M. kansasii isolates were recovered only by the BACTEC 460.

43 Mycobacterium kansasii isolation is more common in HIV-positive person

44 results can occur due to the presence of M. kansasii, M. avium, and possibly other Mycobacterium spe

45 ial species: M. avium, M. intracellulare, M. kansasii, M. chelonae group, M. gordonae, M. xenopi, and

46 of clinically relevant slow growers like M. kansasii, M. szulgai, M. gordonae, and M. asiaticum; how

47 ycobacteria, related to "M. canettii" and M. kansasii, modern M. tuberculosis probably became more hy

48 containing M. bovis (n = 128), Mycobacterium kansasii (n = 10), and Mycobacterium avium subsp. paratu

49 r acid-fast bacilli) that grew Mycobacterium kansasii on culture.

50 with pyrazinamide to include M. avium and M. kansasii, organisms usually not susceptible to pyrazinam

51 ients, 16 (17%) satisfied all criteria for M kansasii pulmonary infection.

52 our of seven patients with culture-proven M. kansasii pulmonary infections yielded one or more false-

53 ive identification of M. tuberculosis and M. kansasii, respectively, and as guides for initial probe

54 els a route from environmental Mycobacterium kansasii, through intermediate "Mycobacterium canettii",

55 uld be presumptively treated for pulmonary M kansasii until final culture results are available.

56 Mycobacterium smegmatis and Mycobacterium kansasii were used as models of Mycobacterium tuberculos

57 articipants had pulmonary NTM disease and M. kansasii with a prevalence of 69.2% [95% CI: 63.2-74.7%]

58 tients' sputum cultures yielded growth of M. kansasii within 6 to 12 days, and the fifth produced gro